Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

45

INTERCEPT PHARMAS

45845PAA6Bond

45845PAA6 (INTERCEPT PHARMAS) is held by 2 institutional investors as of Q2 2023.

Top Holders

Fund ownership
Fund holdings as of
Funds holding2
Value of reported holdings$9.8M
Funds buying / selling
Not available

No holders found

No institutional holders are currently tracking this security.

Loading insider trades…
Loading Congress trades…
Loading activist filings…

Questions investors ask about 45845PAA6

Who owns INTERCEPT PHARMAS?

2 institutional investors held INTERCEPT PHARMAS on June 30, 2023, according to their 13F filings.

How many hedge funds hold INTERCEPT PHARMAS?

2 institutional investors reported INTERCEPT PHARMAS in their 13F filings for the quarter ended June 30, 2023, $9.8M in all.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used